UNSPSC 51372123: Hydrocodone hydrochloride

This classification denotes an opioid receptor agonist and opioid and antitussive agent with the molecular formula C18H21NO3.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QKZ0920OV3. European Medicines Agency schedules hydrocodone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14131MIG. The term hydrocodone hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule hydrocodone hydrochloride under HS 29391100.

As of Q4 2014, HYDROCODONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2C(=O)CC[C@H]3[C@H]1C5)OC.CL.

UNSPSC 51372123 Hydrocodone hydrochloride is a Commodity code that represents controlled pharmaceutical products procured by state and local health agencies to support clinical operations and community health initiatives. Recent state and local solicitation activity under this code shows minimal direct purchasing of hydrocodone itself; instead, issuing bodies are acquiring naloxone and drug deactivation systems, indicating that state and local procurement offices may be tagging opioid-related pharmaceutical purchases and harm-reduction equipment under related codes within the controlled-substances family. Seminole County, Florida, represents the primary recent issuing body visible in the market, sourcing both naloxone and safe drug deactivation systems through competitive bidding. The scope of work involves procurement of finished pharmaceutical products and ancillary medical safety equipment for delivery to designated public-health facilities, with vendors required to manage logistics, maintain insurance coverage including commercial general liability and workers' compensation, and comply with federal workplace and immigration verification standards.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems, with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida, and a response deadline of July 26, 2023. The contract carries an initial two-year term with a one-year renewal option and is potentially funded through FEMA, subjecting vendors to federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Geographic activity is limited to Florida based on recent opportunities, and the procurement does not identify explicit set-aside designations or enterprise restrictions. The source contains only a single recent opportunity tagged to this code, suggesting limited state and local purchasing volume under UNSPSC 51372123 proper.